The Long Run with Luke Timmerman

Timmerman Report
undefined
Dec 14, 2020 • 58min

Ep83: David Lee on Impact in Pharmaceuticals

David Lee, CEO of Servier Pharma, on a nonprofit model.
undefined
Nov 23, 2020 • 59min

Ep82: Andrew Farnum on Medicines From Unusual Traits

Andrew Farnum, CEO of Variant Bio, on drug discovery based on rare genetic traits.
undefined
Nov 12, 2020 • 1h 7min

Ep81: Simba Gill on Microbiome Therapies

Simba Gill, CEO of Evelo Biosciences, on microbiome therapies.
undefined
Oct 28, 2020 • 52min

Ep80: Peter Kolchinsky on Pharma's Soul

Peter Kolchinsky of RA Capital on making drugs affordable, and keeping incentives for drug discovery.
undefined
Oct 26, 2020 • 1h 10min

Ep79: Daphne Koller on Machine Learning for Drug Discovery

Daphne Koller, CEO of insitro, on machine learning for drug discovery
undefined
Oct 13, 2020 • 1h 6min

Ep78: Pearl Huang on Exoneural Cancer Biology

Pearl Huang, CEO of Cygnal Therapeutics, on Exoneural Cancer Biology
undefined
Sep 29, 2020 • 1h 21min

Ep77: Jennifer Petter on Drugging RNA Targets

Jennifer Petter, CSO of Arrakis Therapeutics, on small molecule drugs for RNA targets
undefined
Sep 8, 2020 • 1h 9min

Ep76: Otello Stampacchia on Becoming a Biotech VC

Otello Stampacchia on becoming a biotech venture capitalist.
undefined
Aug 10, 2020 • 1h 4min

Ep75: Rosana Kapeller on Drugging the Repeatome

Rosana Kapeller, CEO of ROME Therapeutics
undefined
Jul 21, 2020 • 1h 16min

Ep74: Abe Ceesay's Path to Leadership

Abe Ceesay, CEO of Tiburio Therapeutics

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app